KEGG   DRUG: Methotrimeprazine
Entry
D00403                      Drug                                   
Name
Methotrimeprazine (USP);
Levomepromazine (USAN/INN);
Levoprome (TN)
Formula
C19H24N2OS
Exact mass
328.1609
Mol weight
328.4717
Structure
Simcomp
Class
Neuropsychiatric agent
 DG01478  Dopamine antagonist
  DG01474  Dopamine D2-receptor antagonist
 DG03200  Antipsychotic agent
  DG01905  Phenothiazine antipsychotics
Remark
Same as: C07192
ATC code: N05AA02
Chemical structure group: DG00868
Product (DG00868): D01520<JP> D02248<JP>
Efficacy
Analgesic
Comment
Phenothiazine derivative
Central nervous system depressant
Target
DRD2 [HSA:1813] [KO:K04145]
  Pathway
hsa04080  Neuroactive ligand-receptor interaction
hsa04728  Dopaminergic synapse
Interaction
Structure map
map07029  Antipsychotics - phenothiazines
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 N NERVOUS SYSTEM
  N05 PSYCHOLEPTICS
   N05A ANTIPSYCHOTICS
    N05AA Phenothiazines with aliphatic side-chain
     N05AA02 Levomepromazine
      D00403  Methotrimeprazine (USP)
Drug groups [BR:br08330]
 Neuropsychiatric agent
  DG01478  Dopamine antagonist
   DG01474  Dopamine D2-receptor antagonist
    DG00868  Levomepromazine
     D00403  Methotrimeprazine
  DG03200  Antipsychotic agent
   DG01905  Phenothiazine antipsychotics
    DG00868  Levomepromazine
     D00403  Methotrimeprazine
Target-based classification of drugs [BR:br08310]
 G Protein-coupled receptors
  Rhodopsin family
   Dopamine
    DRD2
     D00403  Methotrimeprazine (USP)
Drug groups [BR:br08330]
 Neuropsychiatric agent
  DG01478  Dopamine antagonist
   DG01474  Dopamine D2-receptor antagonist
    DG00868  Levomepromazine
  DG03200  Antipsychotic agent
   DG01905  Phenothiazine antipsychotics
    DG00868  Levomepromazine
Other DBs
CAS: 60-99-1
PubChem: 7847469
ChEBI: 6838
LigandBox: D00403
NIKKAJI: J76.892H
LinkDB
KCF data

ATOM        23
            1   C8x C    20.8420  -21.1249
            2   C8x C    20.8420  -22.5291
            3   C8x C    22.1058  -23.2312
            4   C8x C    22.1058  -20.4228
            5   C8y C    23.2993  -21.1249
            6   C8y C    23.2993  -22.5291
            7   S2x S    24.4929  -23.2312
            8   N1y N    24.4929  -20.4228
            9   C8y C    25.6865  -21.1249
            10  C8y C    25.6865  -22.5291
            11  C8x C    26.8099  -23.2312
            12  C8x C    28.0737  -22.5291
            13  C8y C    28.0737  -21.1249
            14  C8x C    26.8801  -20.4228
            15  C1b C    24.4929  -19.0186
            16  C1c C    25.6865  -18.3165
            17  C1b C    25.6865  -16.9123
            18  C1a C    26.8801  -19.0186
            19  N1c N    26.8801  -16.2102
            20  C1a C    26.8801  -14.8060
            21  C1a C    28.1439  -16.9123
            22  O2a O    29.3374  -20.4228
            23  C1a C    30.5310  -21.1249
BOND        25
            1    14   9 1
            2     2   3 2
            3     5   6 2
            4     6   7 1
            5     8  15 1
            6     7  10 1
            7    15  16 1
            8     9   8 1
            9    16  17 1
            10    8   5 1
            11   16  18 1 #Up
            12    3   6 1
            13   17  19 1
            14    5   4 1
            15   19  20 1
            16    4   1 2
            17   19  21 1
            18    1   2 1
            19    9  10 2
            20   10  11 1
            21   11  12 2
            22   12  13 1
            23   13  14 2
            24   13  22 1
            25   22  23 1

» Japanese version   » Back

KEGG   DRUG: Levomepromazine hydrochloride
Entry
D01520                      Drug                                   
Name
Levomepromazine hydrochloride (JAN/USAN);
Nozinan (TN)
Formula
C19H24N2OS. HCl
Exact mass
364.1376
Mol weight
364.9326
Structure
Simcomp
Class
Neuropsychiatric agent
 DG01478  Dopamine antagonist
  DG01474  Dopamine D2-receptor antagonist
 DG03200  Antipsychotic agent
  DG01905  Phenothiazine antipsychotics
Remark
Therapeutic category: 1172
ATC code: N05AA02
Chemical structure group: DG00868
Product (DG00868): D01520<JP> D02248<JP>
Efficacy
Analgesic, Antipsychotic
Comment
Phenothiazine derivative
Target
DRD2 [HSA:1813] [KO:K04145]
  Pathway
hsa04080  Neuroactive ligand-receptor interaction
hsa04728  Dopaminergic synapse
Interaction
Structure map
map07029  Antipsychotics - phenothiazines
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 N NERVOUS SYSTEM
  N05 PSYCHOLEPTICS
   N05A ANTIPSYCHOTICS
    N05AA Phenothiazines with aliphatic side-chain
     N05AA02 Levomepromazine
      D01520  Levomepromazine hydrochloride (JAN/USAN) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
 1  Agents affecting nervous system and sensory organs
  11  Agents affecting central nervous system
   117  Psychotropics
    1172  Phenothiazines
     D01520  Levomepromazine hydrochloride (JAN/USAN)
Drug groups [BR:br08330]
 Neuropsychiatric agent
  DG01478  Dopamine antagonist
   DG01474  Dopamine D2-receptor antagonist
    DG00868  Levomepromazine
     D01520  Levomepromazine hydrochloride
  DG03200  Antipsychotic agent
   DG01905  Phenothiazine antipsychotics
    DG00868  Levomepromazine
     D01520  Levomepromazine hydrochloride
Target-based classification of drugs [BR:br08310]
 G Protein-coupled receptors
  Rhodopsin family
   Dopamine
    DRD2
     D01520  Levomepromazine hydrochloride (JAN/USAN) <JP>
Drug groups [BR:br08330]
 Neuropsychiatric agent
  DG01478  Dopamine antagonist
   DG01474  Dopamine D2-receptor antagonist
    DG00868  Levomepromazine
  DG03200  Antipsychotic agent
   DG01905  Phenothiazine antipsychotics
    DG00868  Levomepromazine
Other DBs
CAS: 1236-99-3
PubChem: 7848583
ChEBI: 31773
LigandBox: D01520
NIKKAJI: J349.699F
LinkDB
KCF data

ATOM        24
            1   S2x S    22.4684  -23.2234
            2   N1y N    22.4684  -20.4199
            3   C8y C    23.6782  -21.1208
            4   C8y C    23.6723  -22.5226
            5   C8x C    24.8832  -23.2285
            6   C8x C    26.1001  -22.5330
            7   C8y C    26.1060  -21.1312
            8   C8x C    24.8951  -20.4252
            9   C8y C    21.2515  -22.5226
            10  C8y C    21.2515  -21.1208
            11  C8x C    20.0374  -20.4199
            12  C8x C    18.8236  -21.1208
            13  C8x C    18.8236  -22.5226
            14  C8x C    20.0374  -23.2234
            15  C1b C    22.4621  -19.0252
            16  C1c C    23.6728  -18.3243
            17  C1b C    23.6728  -16.9295
            18  N1c N    24.8834  -16.2286
            19  C1a C    24.8834  -14.8340
            20  C1a C    24.8871  -19.0243
            21  C1a C    26.0977  -16.9288
            22  O2a O    27.3240  -20.4348
            23  C1a C    28.5257  -21.1356
            24  X   Cl   32.5418  -20.6190
BOND        25
            1     3   2 1
            2     2  10 1
            3     9  10 2
            4    10  11 1
            5    11  12 2
            6    12  13 1
            7    13  14 2
            8    14   9 1
            9     3   4 2
            10    2  15 1
            11    4   5 1
            12   15  16 1
            13    5   6 2
            14   16  17 1
            15    6   7 1
            16   17  18 1
            17    7   8 2
            18   18  19 1
            19    8   3 1
            20   16  20 1 #Up
            21   18  21 1
            22    9   1 1
            23    1   4 1
            24    7  22 1
            25   22  23 1

» Japanese version   » Back

KEGG   DRUG: Levomepromazine maleate
Entry
D02248                      Drug                                   
Name
Levomepromazine maleate (JP18/USAN);
Hirnamin (TN)
Formula
C19H24N2OS. C4H4O4
Exact mass
444.1719
Mol weight
444.5438
Structure
Simcomp
Class
Neuropsychiatric agent
 DG01478  Dopamine antagonist
  DG01474  Dopamine D2-receptor antagonist
 DG03200  Antipsychotic agent
  DG01905  Phenothiazine antipsychotics
Remark
Therapeutic category: 1172
ATC code: N05AA02
Chemical structure group: DG00868
Product (DG00868): D01520<JP> D02248<JP>
Efficacy
Analgesic, Antipsychotic
Comment
Phenothiazine derivative
Target
DRD2 [HSA:1813] [KO:K04145]
  Pathway
hsa04080  Neuroactive ligand-receptor interaction
hsa04728  Dopaminergic synapse
Interaction
Structure map
map07029  Antipsychotics - phenothiazines
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 N NERVOUS SYSTEM
  N05 PSYCHOLEPTICS
   N05A ANTIPSYCHOTICS
    N05AA Phenothiazines with aliphatic side-chain
     N05AA02 Levomepromazine
      D02248  Levomepromazine maleate (JP18/USAN) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
 1  Agents affecting nervous system and sensory organs
  11  Agents affecting central nervous system
   117  Psychotropics
    1172  Phenothiazines
     D02248  Levomepromazine maleate (JP18/USAN)
Drug groups [BR:br08330]
 Neuropsychiatric agent
  DG01478  Dopamine antagonist
   DG01474  Dopamine D2-receptor antagonist
    DG00868  Levomepromazine
     D02248  Levomepromazine maleate
  DG03200  Antipsychotic agent
   DG01905  Phenothiazine antipsychotics
    DG00868  Levomepromazine
     D02248  Levomepromazine maleate
Target-based classification of drugs [BR:br08310]
 G Protein-coupled receptors
  Rhodopsin family
   Dopamine
    DRD2
     D02248  Levomepromazine maleate (JP18/USAN) <JP>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
 Chemicals
  D02248  Levomepromazine maleate
Drug groups [BR:br08330]
 Neuropsychiatric agent
  DG01478  Dopamine antagonist
   DG01474  Dopamine D2-receptor antagonist
    DG00868  Levomepromazine
  DG03200  Antipsychotic agent
   DG01905  Phenothiazine antipsychotics
    DG00868  Levomepromazine
Other DBs
CAS: 7104-38-3
PubChem: 7849307
LigandBox: D02248
NIKKAJI: J231.544K
LinkDB
KCF data

ATOM        31
            1   C8x C    16.1381  -21.1212
            2   C8x C    16.1381  -22.5253
            3   C8x C    17.3549  -23.2272
            4   C8x C    17.3549  -20.4194
            5   C8y C    18.5248  -21.1212
            6   C8y C    18.5248  -22.5253
            7   S2x S    19.7416  -23.2272
            8   N1y N    19.6948  -20.4194
            9   C8y C    20.9584  -21.1212
            10  C8y C    20.9584  -22.5253
            11  C8x C    22.1751  -23.2741
            12  C8x C    23.3921  -22.5720
            13  C8y C    23.3920  -21.1681
            14  C8x C    22.1751  -20.4661
            15  C1b C    19.6948  -19.0153
            16  C1c C    20.9584  -18.3601
            17  C1b C    20.9584  -16.9561
            18  C1a C    22.1285  -19.0621
            19  N1c N    22.1752  -16.2540
            20  C1a C    22.1752  -14.8502
            21  C1a C    23.3921  -16.9561
            22  O2a O    24.6138  -20.4624
            23  C1a C    25.8005  -21.1474
            24  C6a C    33.8311  -21.1375
            25  C2b C    33.1345  -19.9301
            26  O6a O    33.1345  -22.2987
            27  O6a O    35.1780  -21.1375
            28  C2b C    31.5090  -19.9301
            29  C6a C    30.8124  -21.1375
            30  O6a O    29.4654  -21.1375
            31  O6a O    31.5090  -22.2987
BOND        32
            1    14   9 1
            2     2   3 2
            3     5   6 2
            4     6   7 1
            5     8  15 1
            6     7  10 1
            7    15  16 1
            8     9   8 1
            9    16  17 1
            10    8   5 1
            11   16  18 1 #Up
            12    3   6 1
            13   17  19 1
            14    5   4 1
            15   19  20 1
            16    4   1 2
            17   19  21 1
            18    1   2 1
            19    9  10 2
            20   10  11 1
            21   11  12 2
            22   12  13 1
            23   13  14 2
            24   13  22 1
            25   22  23 1
            26   24  25 1
            27   24  26 1
            28   24  27 2
            29   25  28 2
            30   28  29 1
            31   29  30 1
            32   29  31 2

» Japanese version   » Back

DBGET integrated database retrieval system